Impact of inadequate empirical therapy on the mortality of patients with bloodstream infections: A propensity score-based analysis

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 1, 2012, Pages 472-478

  Retamar, Pilar ^a   Portillo, María M ^a   López Prieto, María Dolores ^b   Rodríguez López, Fernando ^c   De Cueto, Marina ^a   García, María V ^d   Gómez, María J ^e   Del Arco, Alfonso ^f   Muñoz, Angel ^g   Sánchez Porto, Antonio ^h   Torres Tortosa, Manuel ⁱ   Martín Aspas, Andrés ^j   Arroyo, Ascensión ^k   García Figueras, Carolina ^b   Acosta, Federico ^l   Corzo, Juan E ^m   León Ruiz, Laura ⁿ   Escobar Lara, Trinidad ^o   Rodríguez Baño, Jesús ^a,p   Natera, Clara ^c   Nuño, Enrique ^d   Herrero, Marta ^e   Fernández Sánchez, Fernando ^f   Pérez Santos, María J ^g   Téllez, Francisco ^h   Becerril, Berta ⁱ   García Tapia, Ana ^j   Carazo, Inmaculada ^q   Alados, Juan C ^l   Moya, Raquel ^b   Florez, Carmen ^m   Navas, Petra ⁿ   Muñoz, Leopoldo ^o   more..

^a HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^b Hospital del SAS   (Spain)

^c HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^e HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^f HOSPITAL COSTA DEL SOL   (Spain)

^g Hospital de la Serrania   (Spain)

^h Unidad de Enfermedades Infecciosas Hospital de La Línea   (Spain)

ⁱ HOSPITAL PUNTA DE EUROPA   (Spain)

^j HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

^k Sección de Enfermedades Infecciosas   (Spain)

^l HOSPITAL DE ANTEQUERA   (Spain)

^m HOSPITAL UNIVERSITARIO DE VALME   (Spain)

ⁿ HOSPITAL TORRECÁRDENAS   (Spain)

^o HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^p UNIVERSITY OF SEVILLE   (Spain)

^q Servicio de Microbiologia   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; POLYPEPTIDE ANTIBIOTIC AGENT; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ADULT; AGED; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BLOODSTREAM INFECTION; CHARLSON INDEX; COHORT ANALYSIS; DISEASE SEVERITY; EMPIRICAL THERAPY; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUTROPENIA; PITT SCORE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM; SEPSIS; SEPTIC SHOCK; SPAIN; THERAPY; TREATMENT OUTCOME;

AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; DRUG RESISTANCE, BACTERIAL; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; LOGISTIC MODELS; MALE; MEDICAL ERRORS; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PROPENSITY SCORE; PROSPECTIVE STUDIES; RISK FACTORS; SPAIN; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84455173002     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00462-11     Document Type: Article

References (30)

1. Arias CA, Murray BE. 2009. Antibiotic-resistant bugs in the 21st century: a clinical super-challenge. N. Engl. J. Med. 360:439-443.
2. Chang FY, et al. 2003. Staphylococcus aureus bacteremia. Recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine (Baltimore, MD) 82:323-329.
3. Charlson ME, Pompei P, Ales KL, MacKenzie CR. 1987. A new method of classifying prognostic co-morbidity in longitudinal studies: development and validation. J. Chronic Dis. 40:373-383. (Pubitemid 17055592)
4. Chow JW, et al. 1991. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann. Intern. Med. 115: 585-590.
5. Cisneros-Herreros JM, Cobo-Reinoso J, Pujol-Rojo M, Rodríguez- Baño J, Salavert-Lletí M. 2007. Guía para el diagnóstico y tratamiento del paciente con bacteriemia. Guías de la Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC). Enferm. Infecc. Microbiol. Clin. 25:111-130. (Pubitemid 46363227)
6. Clinical and Laboratory Standards Institute. 2010. Performance standards for antimicrobial susceptibility testing. 20th informational supplement. Approved standard M100-S20. Clinical and Laboratory Standards Institute, Wayne, PA.
7. D'Agostino RB, Jr. 1998. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat. Med. 17:2265-2281.
8. Friedman ND, et al. 2002. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann. Intern. Med. 130:791-797. (Pubitemid 35334450)
9. Harbarth S, et al. 2003. Inappropriate initial antimicrobial therapy and its effect on survival on a clinical trial of immunomodulating therapy for severe sepsis. Am. J. Med. 115:529-535. (Pubitemid 37352798)
10. Hilf M, et al. 1989. Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am. J. Med. 87:540-546. (Pubitemid 19274758)
11. Hill PC, et al. 1991. Prospective study of 424 cases of Staphylococcus aureus bacteremia: determination of factors affecting incidence and mortality. Intern. Med. J. 31:97-103.
12. Horan TC, Andrus M, Dudeck MA. 2008. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am. J. Infect. Control 36:309-332. (Pubitemid 351763841)
13. Kim SH, et al. 2006. Outcome of inappropriate empirical antibiotic therapy in patients with Staphylococcus aureus bacteraemia: analytical strategy using propensity scores. Clin. Microbiol. Infect. 12:13-21.
14. Lesens O, et al. 2003. Role of comorbidity in mortality related to Staphylococcus aureus bacteremia: a prospective study using the Charlson weighted index of comorbidity. Infect. Control Hosp. Epidemiol. 24: 890-896. (Pubitemid 38029555)
15. Levy MM, et al. 2003. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definition Conference. Crit. Care Med. 31:1250-1256. (Pubitemid 36444440)
16. Lin MY, Weinstein RA, Hota B. 2008. Delay of active antimicrobial therapy and mortality among patients with bacteremia: impact of severe neutropenia. Antimicrob. Agents Chemother. 52:3188-3194.
17. Loza Fernández de Bobadilla E, Planes Reig A, Rodríguez- Creixems M. 2003. Hemocultivos. In Procedimientos en Microbiología Clínica. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica, Madrid, Spain. http://www.seimc.org/ documentos/protocolos/microbiologia. Accessed 30 March 2010.
18. McGregor JC, et al. 2007. A systematic review of the methods used to assess the association between appropriate antibiotic therapy and mortality in bacteremic patients. Clin. Infect. Dis. 45:329-337. (Pubitemid 47101029)
19. Paterson DL, Rice LB. 2003. Empirical antibiotic choice for the seriously ill patient: are minimization of selection of resistant organisms and maximization of individual outcome mutually exclusive? Clin. Infect. Dis. 36: 1006-1012. (Pubitemid 36513286)
20. Paterson DL, et al. 2004. International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum betalactamase production in nosocomial infections. Ann. Intern. Med. 140: 26-32. (Pubitemid 38055918)
21. Paul M, Fraser AA, Leibovici L. 2007. Propensity-matched analysis of appropriate empirical antibiotic treatment. Clin. Infect. Dis. 44: 1251-1252. (Pubitemid 46651253)
22. Paul M, et al. 2010. Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob. Agents Chemother. 54:4851-4863.
23. Rhee JY, et al. 2009. Scoring systems for prediction of mortality in patients with intensive care unit-acquired sepsis: a comparison of the Pitt bacteremia score and the Acute Physiology and Chronic Health Evaluation II scoring systems. Shock 31:146-150.
24. Rodríguez-Baño J, de Cueto M, Retamar P, Gálvez-Acebal J. 2010. Current management of bloodstream infections. Expert Rev. Anti Infect. Ther. 8:815-819.
25. Rodríguez-Baño J, et al. 2010. Epidemiology and clinical features of community-acquired, healthcare associated and nosocomial bloodstream infections in tertiary and community hospitals. Clin. Microbiol. Infect. 16:1408-1413.
26. Rodríguez-Baño J, et al. 2003. Bacteriemias por Acinetobacter baumannii: características clínicas y pronósticas. Enferm. Infecc. Microbiol. Clin. 21: 242-247. (Pubitemid 36692968)
27. Rodríguez-Baño J, et al. 2010. Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis. Clin. Infect. Dis. 50:40-48.
28. Rodríguez-Creixems M, et al. 2008. Bloodstream infections. Evolution and trends in the microbiology workload, incidence, and etiology, 1985-2006. Medicine 87:234-249.
29. Soriano A, Martínez JA, Mensa J. 2008. Septic shock should be included in multivariable models analysing the effect of empirical antibiotic therapy on mortality. Clin. Infect. Dis. 46:1484-1485.
30. von Elm E, et al. 2008. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. J. Clin. Epidemiol. 61:344-349. (Pubitemid 351289042)